Tuesday, April 11, 2023 10:15:20 AM
Multibillion dollar opportunity with differentiated product.
Hmm well I've been out of the loop on Biotech Values' favorite stocks but I'm going to have to award this one my seal of disapproval.
I just don't see a significant enough differentiation to make a difference in light of Abbott's dominance of the market overall and significant off-label use.
I may just be talking out of my butt though.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
